Top 205 Startups developing AI for Medicine and Healthcare

Nov 29, 2024 | By Siddhant Patel

These startups use machine learning, computer vision and Artificial intelligence for medical diagnosis processes, treatment protocol development, drug development, personalized medicine, patient monitoring and care.
1
Country: USA | Funding: $1.4B
Freenome is connecting patients with next-generation cancer screening and diagnostic tests through the power of artificial intelligence.
2
Country: USA | Funding: $1.3B
Tempus is a technology company that is building the world's largest library of molecular and clinical data and an operating system to make that data accessible and to battle cancer.
3
Country: UK | Funding: $1.2B
Babylon is a subscription health service provider that enables users to have virtual consultations with doctors and health care professionals via text and video messaging through its mobile application. Babylon app also uses AI to answer questions you normally ask your family doctor.
4
Country: UK
Google's DeepMind is the world leader in artificial intelligence research and its application in different fields, like games, medicine, energy efficiency.
5
Country: USA | Funding: $865.4M
Drug discovery, reimagined through Artificial Intelligence. We are discovering transformative new treatments by leveraging the speed of automation with the intelligence of computers. It’s drug discovery at unprecedented pace.
6
Country: USA | Funding: $743M
Insitro is a machine-learning driven drug discovery and development company.
7
Country: South Korea | Funding: $561.1M
Lunit builds data-driven imaging biomarker (DIB) technology for image-based disease screening.
8
Country: UK | Funding: $474.4M
Exscientia is applying AI and big data processing to accelerate drug discovery and development.
9
Country: USA | Funding: $466.5M
Spring uses AI to help patients with mental health problems feel better faster. The startup operates as an online mental health clinic for employers, using proprietary machine-learning technology to provide personalized treatment recommendations with hopes that they will be more effective.
10
Country: Singapore | Funding: $463.6M
Biofourmis is reinventing remote patient monitoring by detecting personalized patterns predictive of patient’s health deterioration
11
Country: USA | Funding: $457.5M
Abridge is a medical conversation AI startup that offers an audio-based system to record and summarize medical conversations.
12
Country: USA | Funding: $457M
Metagenomi is using the power of metagenomics and machine learning to discover novel genome editing systems.
13
Country: Portugal | Funding: $453.5M
SWORD Health is a medical company that created the first AI-powered digital physical therapist, shifting healthcare from analog to digital.
14
Country: USA | Funding: $418.7M
K Health has built the first HIPAA compliant AI health app 100% fueled by data, empowering users worldwide to take control of their health. By working with a unique data set of over a billion health interactions, K Health is able to generate better and more accurate insights based on PLM (a.k.a. “People Like Me”), a new approach to understanding our health that looks at other people like us who have had similar experiences.
15
Country: Hong Kong | Funding: $401.3M
Artificial Intelligence for Drug Discovery and Aging Research.
16
Country: USA | Funding: $387.5M
Caresyntax is a digital surgery platform that uses proprietary software and AI to deliver actionable insights to improve patient outcomes.
17
Country: USA | Funding: $355.2M
PathAI's goal is to improve cancer diagnosis using artificial intelligence. PathAI’s services solve the most challenging pathology problems faced by the research and pharmaceutical industry.
18
Country: USA | Funding: $328M
Clarify Health Solutions develops AI analytics software solutions that enable health systems to deliver more satisfying, better outcome and higher value care
19
Country: USA | Funding: $324.9M
Flatiron Health is a healthcare technology and services company focused on accelerating cancer research and improving patient care. It uses machine-learning algorithms to analyse the world’s largest real-world oncology data source.
20
Country: USA | Funding: $324.3M
Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins
Editor: Siddhant Patel
Siddhant Patel is a senior editor for AI-Startups. He is based out of India and has previously worked at publications including Huffington Post and The Next Web. Siddhant has a special interest in artificial intelligence and has spent a decade covering the rapidly-evolving business and technology of the industry. Siddhant graduated from the Indian Institute of Science (Bengaluru). When he’s not writing, Siddhant is also a developer and has a deep historical knowledge of the computer industry for the past 50 years. You can contact Siddhant at sidpatel(at)ai-startups(dot)org